| 0.774 -0.003 (-0.41%) | 10-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.08 | 1-year : | 1.22 |
| Resists | First : | 0.93 | Second : | 1.04 |
| Pivot price | 0.84  |
|||
| Supports | First : | 0.74 | Second : | 0.61 |
| MAs | MA(5) : | 0.77 |
MA(20) : | 0.83 |
| MA(100) : | 1.02 |
MA(250) : | 1.12 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 8.8  |
D(3) : | 7.7 |
| RSI | RSI(14): 40.7 |
|||
| 52-week | High : | 1.93 | Low : | 0.74 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HYPR ] has closed above bottom band by 19.0%. Bollinger Bands are 8.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.78 - 0.78 | 0.78 - 0.79 |
| Low: | 0.74 - 0.74 | 0.74 - 0.75 |
| Close: | 0.76 - 0.77 | 0.77 - 0.78 |
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Mon, 12 Oct 2026
Full Transcript: Hyperfine Q2 2026 Earnings Call - Benzinga
Thu, 08 Oct 2026
Hyperfine Inc (HYPR) Projects 55% Revenue Growth for Fiscal 2026 - GuruFocus
Thu, 08 Oct 2026
Hyperfine (HYPR) Reports Improved Q3 Cash Burn and Strong Revenue Growth Amid Valuation Concerns - GuruFocus
Thu, 08 Oct 2026
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026 - Business Wire
Thu, 08 Oct 2026
Preliminary Q3 revenue rises 55% year over year at Hyperfine (HYPR), topping net cash burn for the first time. - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 91 (M) |
| Shares Float | 86 (M) |
| Held by Insiders | 4.4 (%) |
| Held by Institutions | 22.5 (%) |
| Shares Short | 3,900 (K) |
| Shares Short P.Month | 3,650 (K) |
| EPS | -0.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.34 |
| Profit Margin | -210.8 % |
| Operating Margin | -217 % |
| Return on Assets (ttm) | -38.9 % |
| Return on Equity (ttm) | -97 % |
| Qtrly Rev. Growth | 44.7 % |
| Gross Profit (p.s.) | 0.09 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.36 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -27 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -2.1 |
| PEG Ratio | 0 |
| Price to Book value | 2.21 |
| Price to Sales | 4.25 |
| Price to Cash Flow | -2.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|